Fludarabine, Cyclophosphamide, Rituximab, and Stem Cell Transplant In Treating Patients With Severe Systemic Lupus Erythematosus

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00726518

Sponsors and Collaborators

Investigators